Device / Technology News

RSS

Nontoxic gold nanoparticles could detect growth of early tumors in liver

Hepatocellular carcinoma is the most common cancer to strike the liver. More than 500,000 people worldwide, concentrated in sub-Saharan Africa and Southeast Asia, are diagnosed with it yearly. Most of those afflicted die within six months.

23 Jun 2011

Loyola offers powerful new MRI machine without usual inconveniences

Loyola University Health System now offers a powerful new MRI machine that can scan a leg or an arm without many of the usual inconveniences.

23 Jun 2011

Simple non-invasive breath test could accurately detect vitamin B12 deficiency

Researchers have developed a new test to detect the levels of vitamin B12 using your breath, allowing for a cheaper, faster, and simpler diagnosis that could help to avoid the potentially fatal symptoms of B12 deficiency.

23 Jun 2011

BioCision releases three new cryopreservation systems

BioCision, the coolprep company, today announced the release of three new cryopreservation systems: CoolCell FTS30, the first large-capacity, high-density cell freezing system; CoolCell SV2 for freezing cells in larger diameter 2ml vials; and CoolCell 5ml for large cryovial freezing.

22 Jun 2011

Elavon wins Merchant Acquirer of the Year Award at Cards & Payments European Conference

At a glittering award ceremony at the Westin Grand in Frankfurt last night, Elavon, a leading global payments provider and wholly-owned subsidiary of U.S. Bancorp, was announced as winner of the Merchant Acquirer of the Year Award at the Cards & Payments Europe 2011 Conference and Awards Dinner.

22 Jun 2011

22nd Century submits IND to FDA for VLN cigarettes

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction, announced today that 22nd Century Limited, LLC submitted an Investigational New Drug Application (IND) to the U.S. Food & Drug Administration (FDA) for X-22, a prescription smoking cessation aid in development.

22 Jun 2011

Rapid diagnostic tests for malaria can be improved, says researcher

Rapid diagnostic tests for malaria are simple, reliable and robust. But errors occur, through misuse or because they aren't designed for primitive circumstances. Researcher Philippe Gillet put them to the test and made a series of suggestions for improvement. It resulted in a PhD at the Institute of Tropical Medicine Antwerp and Maastricht University.

22 Jun 2011

Hospice of the Red River Valley selects CellTrak mobile point-of-care application

Hospice of the Red River Valley, an independent, nonprofit hospice organization serving 29 counties across North Dakota and Minnesota, provides care to more than 250 patients each day. Based in Fargo, N.D., Hospice of the Red River Valley has successfully implemented the CellTrak mobile point-of-care application to improve the ability of its Certified Nursing Assistants (CNAs) to deliver more focused and dedicated care.

22 Jun 2011

Two NJIT researchers receive U.S. Patent for nanoprobe array technique

Reginald C. Farrow and Zafer Iqbal, research professors at NJIT, were awarded a patent today for an improved method of fabricating arrays of nanoscale electrical probes. Their discovery may lead to improved diagnostic tools for measuring the spatial variation of electrical activity inside biological cells.

22 Jun 2011

FGS expands service offering to European market through ISO 13485 medical certification

Flextronics Global Services (FGS), a business unit of Flextronics, today announced that it is expanding its service offering to the medical market in Europe through ISO 13485 medical certification at its Budapest facility.

22 Jun 2011

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a U.S. patent relating to a technology for the treatment of cancer for which the Company holds an exclusive, worldwide license.

22 Jun 2011

Celerion generates over 25,000 platelet aggregation samples, achieves major milestone

Celerion, the premier provider of innovative early stage drug development solutions, announces it has achieved a major milestone of generating over 25,000 platelet aggregation sample results.

22 Jun 2011

Integromics announces winners of proteomics grant competition

Integromics, a leader in IT solutions for life sciences in the field of genomics and proteomics, today announces the two winners of the Integromics 'Proteomics Mass Spectrometry Research Grant' competition, for the creative use of Integromics' OmicsHub(R) proteomics solution. The winners are Prof. Stephen Pennington from University College Dublin and Dr. Michelle Cilia from the USDA-ARS (U.S. Department of Agriculture - Agricultural Research Service).

22 Jun 2011

Avedro receives Gold MDEA award for Vedera System

Avedro, Inc. announced today that the Vedera System for performing Keraflex has received the prestigious Gold level 2011 Medical Design Excellence Award.

22 Jun 2011

New VEP technique fast and effective for detecting glaucoma damage

A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.

22 Jun 2011

New technique makes artificial bones more natural

A new technique for producing artificial bone implants has been developed by Korean researchers. Published in the journal Science and Technology of Advanced Material (STAM), the technique combines two methods to approximate both types of bone tissue. By mimicking natural bone, it is hoped the implant material will better complement the natural regeneration process.

21 Jun 2011

Respira reports results of DPI drug engine clinical study against COPD, asthma

Respira Therapeutics, a product development company focused on inhaled therapeutics to improve patients' lives, today announced the results of a clinical feasibility study of the Company's drug engine technology.

21 Jun 2011

NextGen launches first CSF multiplex protein assay for detecting CNS diseases

NextGen Group plc is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first cerebrospinal fluid (CSF) multiple protein assay, csfdiscovery43, for central nervous system (CNS) biomarker discovery and qualification.

21 Jun 2011

US E-Prescription Systems market to reach over $204.67 million by 2017

The US E-Prescription Systems market is forecast to reach $204.67 million, while the European market is forecast to reach $508.38 million by the year 2017, according to a new report on companiesandmarkets.com.

21 Jun 2011

Benefis selects NextGen Ambulatory EHR, Health Information Exchange as technology foundation

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Benefis Health System has selected NextGen Ambulatory EHR, NextGen Practice Management and NextGensm Health Information Exchange as its technology foundation.

21 Jun 2011